2-Chloro-N-(3,4-dimethoxybenzyl)acetamide
Modify Date: 2024-01-06 12:16:00
2-Chloro-N-(3,4-dimethoxybenzyl)acetamide structure
|
Common Name | 2-Chloro-N-(3,4-dimethoxybenzyl)acetamide | ||
|---|---|---|---|---|
| CAS Number | 65836-72-8 | Molecular Weight | 243.68700 | |
| Density | 1.194g/cm3 | Boiling Point | 425.7ºC at 760 mmHg | |
| Molecular Formula | C11H14ClNO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 211.3ºC | |
Use of 2-Chloro-N-(3,4-dimethoxybenzyl)acetamideDKM 2-93 is a relatively selective inhibitor of UBA5 with an IC50 of 430 μM. |
| Name | 2-chloro-N-[(3,4-dimethoxyphenyl)methyl]acetamide |
|---|---|
| Synonym | More Synonyms |
| Description | DKM 2-93 is a relatively selective inhibitor of UBA5 with an IC50 of 430 μM. |
|---|---|
| Related Catalog | |
| Target |
IC50: 430 μM (UBA5), 90 μM (PaCa2 cells), 30 μM (Panc1 cells)[1] |
| In Vitro | Ubiquitin-like modifier activating enzyme 5 (UBA5) is a novel pancreatic cancer therapeutic target. DKM 2-93 impairs pancreatic cancer cell survival through covalently modifying the catalytic cysteine of UBA5, thereby inhibiting its activity as a protein that activates the ubiquitin-like protein UFM1 to UFMylate proteins. DKM 2-93 inhibits PaCa2 and Panc1 cells survival with IC50s of 90 and 30 μM, respectively[1]. |
| In Vivo | DKM 2-93 daily treatment significantly impairs tumor growth of PaCa2 cells in vivo in tumor xenograft studies in immune-deficient mice without causing any weight loss or overt toxicity[1]. |
| Cell Assay | PaCa2 and Panc1 cells are treated with 0-1000 μM DKM 2-93 for 48 hours. Cell viability is assessed by Hoescht stain[1]. |
| Animal Admin | Mice: Mice are subcutaneously injected with PaCa2 cells to initiate the tumor xenograft study and treatments of mice are initiated with vehicle or DKM 2-93 (50 mg/kg ip, once per day) three days after injection of cancer cells[1]. |
| References |
| Density | 1.194g/cm3 |
|---|---|
| Boiling Point | 425.7ºC at 760 mmHg |
| Molecular Formula | C11H14ClNO3 |
| Molecular Weight | 243.68700 |
| Flash Point | 211.3ºC |
| Exact Mass | 243.06600 |
| PSA | 47.56000 |
| LogP | 1.94970 |
| Index of Refraction | 1.522 |
| Storage condition | 2-8℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | Xi |
|---|---|
| HS Code | 2924299090 |
|
~87%
2-Chloro-N-(3,4... CAS#:65836-72-8 |
| Literature: Huynh, Tracey; Valant, Celine; Crosby, Ian T.; Sexton, Patrick M.; Christopoulos, Arthur; Capuano, Ben Journal of Medicinal Chemistry, 2013 , vol. 56, # 20 p. 8196 - 8200 |
|
~%
2-Chloro-N-(3,4... CAS#:65836-72-8 |
| Literature: Quevedo, Rodolfo; Baquero, Edwin; Rodriguez, Mario Tetrahedron Letters, 2010 , vol. 51, # 13 p. 1774 - 1778 |
|
~%
2-Chloro-N-(3,4... CAS#:65836-72-8 |
| Literature: Jacobs; Heidelberger Journal of Biological Chemistry, 1915 , vol. 20, p. 674 |
|
~%
2-Chloro-N-(3,4... CAS#:65836-72-8 |
| Literature: Monti Gazzetta Chimica Italiana, 1930 , vol. 60, p. 777,778 |
| HS Code | 2924299090 |
|---|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
| Chlor-essigsaeure-veratrylamid |
| N-chloroacetyl-3,4-dimethoxybenzylamine |
| C-Chlor-N-veratryl-acetamid |
| 2-chloro-N-(3,4-dimethoxybenzyl)acetamide |
| chloro-acetic acid veratrylamide |
| N-(3.4-Dimethoxy-benzyl)-chloracetamid |
| 2-Chloro-N-((3,4-dimethoxyphenyl)methyl)acetamide |
| N-(Dimethoxy-3,4 benzyl)-chloroacetamide [French] |
| Acetamide,2-chloro-N-((3,4-dimethoxyphenyl)methyl) |
| N-Chloracetyl-(3,4-dimethoxyphenyl)methylamin |
| DKM 2-93 |